Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants (EXODENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03810859
Recruitment Status : Recruiting
First Posted : January 21, 2019
Last Update Posted : April 16, 2019
Sponsor:
Collaborators:
OSCAR
Foundation Maladie Rare
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:
ExoDent specifically aims to discover new genes and new mutations causing isolated amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) and other dentin anomalies. The key point for clinicians is to distinguish between non syndromic and syndromic disorders in order to improve patients guidance and counseling. To do so, two targeted NGS panel have been designed, one searching for isolated AI and the other for DI. After 18 months, some families remain without any positive results. ExoDent project proposes those negative patients a Whole Exome Sequencing (WES) approach to deeper explore their genetic background.

Condition or disease Intervention/treatment Phase
Amelogenesis Imperfecta Dentinogenesis Imperfecta Dentin Anomalies Biological: Blood sample Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants
Estimated Study Start Date : April 2019
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : July 2020


Arm Intervention/treatment
Experimental: All patients
Blood sample
Biological: Blood sample
Adults : 7 to 10 mL Childs : 2 to 4 mL




Primary Outcome Measures :
  1. Genome sequencing [ Time Frame: After one day ]
    Pathogenic variants identification and qualification



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • clinical diagnosis of amelogenesis imperfecta or dentinogenesis imerfecta or other dentin anomaly with no other signs or symptoms ( familial or isolated)
  • negative results after targeted NGS strategy for molecular diagnosis

Exclusion Criteria:

  • absence of positive clinical diagnosis
  • Diagnosis of syndromic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03810859


Contacts
Layout table for location contacts
Contact: Céline GAUCHER, MD (33)1 58 41 12 17 celine.gaucher@parisdescartes.fr
Contact: Caroline TOURTE (33)1 58 41 11 90 caroline.tourte@aphp.fr

Locations
Layout table for location information
France
Hospital Cochin Recruiting
Paris, France, 75014
Contact: Céline GAUCHER, MD    (33)1 58 4112 17    celine.gaucher@parisdescartes.fr   
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
OSCAR
Foundation Maladie Rare
Investigators
Layout table for investigator information
Principal Investigator: Céline GAUCHER, MD APHP

Layout table for additonal information
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT03810859     History of Changes
Other Study ID Numbers: K180404J
2018-A01250-55 ( Other Identifier: ID-RCB )
First Posted: January 21, 2019    Key Record Dates
Last Update Posted: April 16, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Amelogenesis imperfecta
Dentinogenesis imperfecta
Dentin anomalies
Whole Exome Study

Additional relevant MeSH terms:
Layout table for MeSH terms
Congenital Abnormalities
Amelogenesis Imperfecta
Dentinogenesis Imperfecta
Dental Enamel Hypoplasia
Tooth Abnormalities
Stomatognathic System Abnormalities
Stomatognathic Diseases
Tooth Diseases